17-AAG

Supplier: RPI

Synonyms: 17-(Allylamino)-17-demethoxygeldanamycin, Tanespimycin, (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-(Allylamino)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate

A20045-0.0005 A20045-0.001 A20045-0.005
76344-646EA 94.9 USD
76344-646 76344-648 77510-162
17-AAG
17-AAG

17-AAG (17-Allylamino-17-demethoxygeldanamycin) is a synthetic derivative of geldanamycin. Like geldanamycin, 17-AAG is recognised for its role as an inhibitor of heat shock protein 90 (Hsp90), a molecular chaperone involved in protein folding and stabilisation.


It is often used as a tool to study Hsp90-dependent processes. By inhibiting Hsp90, 17-AAG impacts the stability and function of various client proteins, many of which are involved in critical cellular processes, including signal transduction and cell cycle regulation. Similar to geldanamycin, 17-AAG is particularly relevant in cancer research, as Hsp90 is often crucial for the stability of oncoproteins. Researchers use 17-AAG to explore the molecular mechanisms of Hsp90 inhibition, with potential applications in understanding cancer biology and developing therapeutic strategies.


Precaución: Research or further manufacturing use only, not for food or drug use.

Formula: C₃₁H₄₃N₃O₈
MW: 585.7 g/mol
Storage Temperature: Freezer
MDL Number: MFCD04973892
CAS Number: 75747-14-7

Order Now

Specification Test Results

Appearance Purple Powder
Melting Point Report °C
Purity (HPLC) ≥ 98.0 %
Purity (TLC) ≥ 98.0 %
Solubility (10 mg/ml) DMSO, Methanol: Clear purple solution
BSE/TSE Free BSE/TSE Free
Country of Origin Report

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR